BD SurePath™ Pap Test

The time is right for the BD SurePath™ test.

Millions of patients and their doctors rely on the BD SurePath™ liquid-based Pap test every month to ensure their cervical health.

The BD SurePath™ test is:

	The only Pap test with an FDA-approved claim of a 64.4% increase in HSIL+ detection.
	The only Pap test with an FDA-approved claim to significantly reduce Unsatisfactory samples.
	The only Pap test where 100% of the collected sample is transferred to the vial for processing in the lab.
	Compatible with BD FocalPoint™ Imaging System technology for even greater scrutiny of cervical slides to reduce False Negatives.
	FDA-approved for out-of-vial CT/GC testing using the BD ProbeTec™ CT/GC Q^x Amplified DNA Assays.

Did you know?

Unsatisfactory results due to debris in the cervical sample are not only a problem in rescheduling patients debris could result in missed diagnosis.
The BD SurePath™ Cell Enrichment Process removes debris to ensure the lowest Unsat rate and clearest views of cells.

Clinical News

Independent study on the effect of blood on cellularity of cervical sample.

BD SurePath™ Pap test Direct to Vial Clinical Study.

Study shows that rinsing sampling devices does not transfer all the sampled cervical cells to the vial for analysis.